5-HT2 receptor gene locus: Association with schizophrenia or treatment response not detected

Psychiatric Genetics

Volumn 6, Issue 1, 1996, Pages 23-27

  Nimgaonkar, V L ^a   Zhang, X R ^a   Brar, J S ^a   DeLeo, M ^a   Ganguli, R ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

5 HT2 receptor gene; Association; Genetics; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT; SEROTONIN 2 RECEPTOR; SEROTONIN RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RECEPTOR GENE; SCHIZOPHRENIA; TREATMENT OUTCOME; ALLELE; CASE CONTROL STUDY; CAUCASIAN; COHORT ANALYSIS; DRUG RESISTANCE; GENETICS; LABORATORY DIAGNOSIS; NEGRO;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; DRUG RESISTANCE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FALSE NEGATIVE REACTIONS; FEMALE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC; RECEPTORS, SEROTONIN; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0029670417     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-199621000-00005     Document Type: Article

References (23)

1. Arranz MJ, Sodhi MS, Ball D, Sham PC, Curtis DA, Collier DA and Kerwin R (1995) Allelic association of 5-HT2A and response to clozapine. Psychiatric Genetics, 5, 45.
2. Bennett JP, Enna SJ, Bylund DB, Gillin J, Wyatt R and Snyder S (1979) Neurotransmitter receptors in frontal cortex of schizophrenics. Archives of General Psychiatry, 36, 927-934.
3. Bodmer W (1987) The human genome sequence and the analysis of multifactorial traits. CIBA Foundation Symposium, 130, 215-228.
4. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM and van der Noordaa J (1990) Rapid and simple method for purification of nucleic acids. Journal of Clinical Microbiology, 28, 495-503.
5. Cohen J (1988) Statistical Power Analysis for the Behavioral Sciences, 2nd edn. Lawrence Erlbaum Associates, Hillsdale, NJ.
6. Cole JO, GSC, David JM (1966) Drugs in the treatment of psychosis; controlled studies. In: Psychiatric Drugs (Ed. P Solomon), pp. 153-180. Grune and Stratton, New York.
7. Cooper DN and Clayton JF (1988) DNA polymorphism and the study of disease associations. Human Genetics, 78, 299-312.
8. Csernansky JG et al. (1985) Problems in classification of schizophrenics as neuroleptic responders and non-responders. Journal of Nervous and Mental Diseases, 173, 325-331.
9. Eaves LJ, Kendler KS and Schulz SC (1986) The familial sporadic classification: its power for the resolution of genetic and environmental aetiological factors. Journal of Psychiatric Research, 20, 115-130.
10. Falk CT and Rubinstein P (1987) Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Annals of Human Genetics, 51 (Pt 3), 227-233.
11. Gottesman I (1991) Schizophrenia Genesis: The Origins of Madness. WH Freeman, New York.
12. Gottesman II (1994) Complications to the complex inheritance of schizophrenia [Review]. Clinical Genetics, 46 (1 Spec No), 116-123.
13. Inayama Y, Yoneda H, Ishida T, Nonomura Y, Kono Y, Koh J, Kuroda K, Higashi H, Asaba H and Sakai T (1994) An association between schizophrenia and a serotonin receptor DNA marker (5HTR2). Neuropsychopharmacology, 10, 56S.
14. Kolakowska T et al. (1985) Schizophrenia with good and poor outcome. 1. Early clinical features, response to neuroleptics and signs of organic dysfunction. British Journal of Psychiatry, 146, 229-239.
15. McGuffin P, Farmer AE and Harvey I (1991) A polydiagnostic application in studies of psychotic illness. Archives of General Psychiatry, 48, 764-770.
16. Meltzer HY (1989) Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology 99, S18-S27.
17. Miller SA, Dykes DD and Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 16, 1215.
18. Mourant AE, Kopec AC and Domaniewska-Sobczak K (1978) Blood Groups and Diseases. Oxford University Press, Oxford.
19. Nimgaonkar VL et al. (1988) Response to drugs in schizophrenia: the influence of family history, obstetric complications and ventricular enlargement. Psychological Medicine, 18, 538-592.
20. Spitzer R, Endicott J and Robins E (1977) Research Diagnostic Criteria for a Selected Group of Functional Disorders, 3rd edn. New York State Psychiatric Institute, New York.
21. Spurlock G, Williams J, Daniels J, Owen M and McGuffin P (1995) The European multi-centre study of susceptibility gene associations in schizophrenia: typing the 5HT-2R gene. Psychiatric Genetics, 5, 64-65.
22. Suarez BK and Hampe CL (1994) Linkage and association. American Journal of Human Genetics, 54, 554-559.
23. Warren JJT, Peacock ML et al. (1993) An MspI polymorphism in the human serotonergic receptor gene (HTR2): detection by DGGE and RFLP analysis. Human Molecular Genetics, 2, 338.